학술논문
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
Document Type
Article
Author
Devos, T.; Geukens, T.; Cleeren, M.; Verhamme, P.; Meyfroidt, G.; Schauvlieghe, A.; Lambrecht, B.N.; Ariën, K.K.; van Griensven, J.; Barbezange, C.; Romano, M.; Compernolle, V.; Dauby, N.; Desmecht, D.; Moutschen, M.; Grimaldi, D.; Luyten, A.; Vandenberghe, K.; Maes, P.; Liesenborghs, L.; Seyler, L.; Nevessignsky, M.T.; Verbeke, G.; Vlieghe, E.; Yombi, J.C.
Source
In: Trials . (Trials, December 2020, 21(1))
Subject
Language
English
ISSN
17456215